InspireMD, Inc.
NSPRStock
$0.71−68.70%52W
Market Cap$33.72M
P/E—
Div yield—
Beta0.80
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-69.68%
Price vs S&P 500 (4W)0.47%
VGM Score55.32
Market Capitalization$33.72M
Earnings Surprise History
Q1 26-0.16est. -0.18
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.11
4.11
4.11
4.11
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NSPRInspireMD, Inc. | B | B | D | $0.71 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
InspireMD is a U.S.-based medical device company specializing in proprietary MicroNet stent platform technology for treating complex vascular and coronary disease. Its primary revenue driver is the CGuard carotid Embolic Prevention System, which combines the company's proprietary MicroNet technology with a self-expandable stent for carotid artery applications. The company also offers the MGuard Prime Embolic Protection System and maintains operations across Europe and Russia.